Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA MAGI2‐AS3/miR‐218‐5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma
Cheng Cao, Shao Zhou, Jiandao Hu
International Forum of Allergy & Rhinology (2020) Vol. 10, Iss. 8, pp. 1012-1023
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A fishnet between nasopharyngeal carcinoma and resistance: the competing endogenous RNA network
Mingtai Li, Ting‐Shan Mo, Zisha Yang, et al.
Current Treatment Options in Oncology (2025)
Closed Access
Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p
Jingjing Zhang, Rui Wang
Experimental Gerontology (2020) Vol. 144, pp. 111180-111180
Closed Access | Times Cited: 56
Roles of lncRNA MAGI2-AS3 in human cancers
Kaixin Liu, Cheng Cheng, Rui Li, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111812-111812
Open Access | Times Cited: 33
The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma
Haoyuan Xu, Wanpeng Li, Dehui Wang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines
Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 526-526
Open Access | Times Cited: 17
Insight into LncRNA- and CircRNA-Mediated CeRNAs: Regulatory Network and Implications in Nasopharyngeal Carcinoma—A Narrative Literature Review
Senmiao Zhang, Yanling Li, Shuyu Xin, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4564-4564
Open Access | Times Cited: 16
Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis
Feng Yuan, Zhiping Lou, Zhifeng Zhou, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 4
Open Access | Times Cited: 22
Novel insights for lncRNA MAGI2-AS3 in solid tumors
Chen Xue, Ganglei Li, Juan Lü, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111429-111429
Open Access | Times Cited: 22
MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
Faezeh Tolue Ghasaban, Amirhosein Maharati, Amir Sadra Zangouei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters
Luděk Záveský, Eva Jandáková, Vít Weinberger, et al.
Cancer Biomarkers (2024) Vol. 40, Iss. 1, pp. 61-78
Open Access | Times Cited: 2
PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT
Wenchao Zhang, Wei Li, Chi Yin, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2873-2887
Open Access | Times Cited: 2
Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
Hani Sabaie, Nazanin Amirinejad, Mohammad Reza Asadi, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 19
IGF2BP3 Worsens Lung Cancer through Modifying Long Non-coding RNA CERS6-AS1/microRNA-1202 Axis
An Yan, Xiaowei Song, Bao Liu, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 7, pp. 878-891
Closed Access | Times Cited: 11
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
José A. Peña-Flores, Mercedes Bermúdez, Rosalío Ramos‐Payán, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
Trishna Saha, Rajesh Detroja, Sumit Mukherjee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12628-12628
Open Access | Times Cited: 10
New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer’s Disease
Yitong Hao, Bo Xie, Xiaoshu Fu, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1802-1802
Open Access | Times Cited: 9
Role of long non-coding RNA in chemoradiotherapy resistance of nasopharyngeal carcinoma
Yang Yang, QuPing Yuan, Weijian Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
HOXA11‑AS induces cisplatin resistance by modulating the microRNA‑98/PBX3 axis in nasopharyngeal carcinoma
Haineng Li, Jia Huang, Sa Yu, et al.
Oncology Letters (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 12
A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer
Larissa Kotelevets, Eric Chastre
Cancers (2021) Vol. 13, Iss. 17, pp. 4264-4264
Open Access | Times Cited: 11
The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR)
Giuseppina Liguori, Margherita Cerrone, Annarosaria De Chiara, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10160-10160
Open Access | Times Cited: 10
MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells
Xiaoyu Zhang, Xudong Dai, Xin Zhao, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7082-7104
Open Access | Times Cited: 5
Role of MAGI2-AS3 in malignant and non-malignant disorders
Mohammad Taheri, Arian Askari, Bashdar Mahmud Hussen, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154530-154530
Open Access | Times Cited: 2
MAGI2-AS3 hypermethylated in promoter region promotes migration and invasion of head and neck squamous cell carcinoma via miRNA-31-5p/AR axis
Kai Yue, Ting Zhang, Huanhuan Wang, et al.
Translational Oncology (2024) Vol. 52, pp. 102223-102223
Closed Access
A Risk Model Based on Sorafenib-Response Target Genes Predicts the Prognosis of Patients with HCC
Xiang Liu, Jian Zeng, Huanyu Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 2
FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1
Hongjun Dong, Chao Huang, Jingjing Huang
Molecular Medicine Reports (2021) Vol. 24, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top